Page last updated: 2024-10-17

n(1)-methylnicotinamide and Lung Neoplasms

n(1)-methylnicotinamide has been researched along with Lung Neoplasms in 2 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"Full pharmacokinetic profiles of nicotinamide concentrations in plasma were analyzed repeatedly in 15 patients to determine the inter- and intra-patient variability in peak plasma concentrations and the optimum times for administering nicotinamide as a radiosensitizer."2.69Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer. ( Bernier, J; Bieri, S; Bolla, M; Denekamp, J; Dennis, MF; Hagen, F; Kocagöncü, O; Rojas, A; Stratford, MR, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blazejczyk, A1
Switalska, M1
Chlopicki, S1
Marcinek, A1
Gebicki, J1
Nowak, M1
Nasulewicz-Goldeman, A1
Wietrzyk, J1
Bernier, J1
Stratford, MR1
Denekamp, J1
Dennis, MF1
Bieri, S1
Hagen, F1
Kocagöncü, O1
Bolla, M1
Rojas, A1

Trials

1 trial available for n(1)-methylnicotinamide and Lung Neoplasms

ArticleYear
Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1998, Volume: 48, Issue:2

    Topics: Administration, Oral; Area Under Curve; Carbon Dioxide; Carcinoma; Carcinoma, Non-Small-Cell Lung; C

1998

Other Studies

1 other study available for n(1)-methylnicotinamide and Lung Neoplasms

ArticleYear
1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis.
    Journal of experimental & clinical cancer research : CR, 2016, 07-13, Volume: 35, Issue:1

    Topics: Animals; Cadherins; Cdh1 Proteins; Cell Line, Tumor; Epoprostenol; Female; Gene Expression Regulatio

2016